Loading clinical trials...
Loading clinical trials...
Cellular Infusions in Patients With Recurrent or Persistent Hematologic Malignancies After Allogeneic Stem Cell Transplant
Conditions
Interventions
donor lymphocytes
Locations
1
United States
Roswell Park Cancer Institute
Buffalo, New York, United States
Start Date
October 1, 2003
Primary Completion Date
July 26, 2018
Completion Date
July 26, 2018
Last Updated
August 26, 2020
NCT00106925
NCT06337318
NCT07388563
NCT06285890
NCT05529069
NCT06311227
Lead Sponsor
Roswell Park Cancer Institute
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions